Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-01-07 @ 7:02 AM
Study NCT ID:
NCT02019433
Status:
TERMINATED
Last Update Posted:
2017-01-26
First Post:
2013-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®
Sponsor:
Aesculap AG
Organization:
Study Overview
Official Title:
Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®
Status:
TERMINATED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Implant Survival as well as clinical and radiological Follow-Up of acetabular Titan-Augment Structan®
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: